- Home
- Home
- Supplements
- Huperzine A
Huperzine A
Huperzia serrata extract
TL;DR
Huperzine A is a potent acetylcholinesterase inhibitor from club moss, dosed at 50-200 mcg. Effective but drug-like, with a long half-life and real side effects.
Ideal For
- Adults seeking short-term memory and learning support, used cyclically
- People stacking with a choline source such as alpha-GPC
- Those researching cholinergic approaches to cognitive decline, with medical input
Avoid If
- You take donepezil, rivastigmine or galantamine
- You have bradycardia or a cardiac conduction disorder
- You have asthma or COPD
- You have epilepsy
- You have peptic ulcer disease
- You are pregnant or breastfeeding
Frequently Asked Questions
Overview
Huperzine A is an alkaloid isolated from Chinese club moss (Huperzia serrata), used in traditional Chinese medicine and developed in China as a treatment for Alzheimer's disease, where it is available as a prescription drug. It is a reversible, highly selective inhibitor of acetylcholinesterase, the enzyme that clears acetylcholine from the synapse — the same mechanism as donepezil and rivastigmine.
This is the key framing point for anyone considering it as a nootropic: huperzine A is not a gentle herbal cognitive enhancer, it is a pharmacologically potent enzyme inhibitor that happens to come from a plant. It is active at microgram doses, crosses the blood-brain barrier readily, and has a plasma half-life of around 10-14 hours with central effects lasting longer. Meta-analyses of Chinese trials in Alzheimer's disease report improvements in MMSE and activities of daily living, though methodological quality is variable and Western replication is limited.
For healthy users, benefits on memory are less clear and the risk profile deserves respect. Continuous daily use leads to receptor downregulation, which is why cycling — five days on, two off, or three weeks on and one off — is the common practice. Cholinergic side effects including nausea, sweating, vivid dreams, muscle cramps and bradycardia are dose-dependent and not rare. It should never be combined with prescription cholinesterase inhibitors.
How It Works
- Reversible and selective inhibition of acetylcholinesterase, raising synaptic acetylcholine
- Crosses the blood-brain barrier efficiently with high central bioavailability
- NMDA receptor antagonism, offering some protection against glutamate excitotoxicity
- Neuroprotective effects against beta-amyloid toxicity in preclinical models
- Long half-life of 10-14 hours, so effects accumulate with daily dosing
Quick Facts
- Increases acetylcholine levels
- Enhances memory formation
- Neuroprotective properties
- Improves learning capacity
- Supports focus and clarity
Benefits & Outcomes
Acetylcholine Enhancement
Huperzine A is a potent, reversible acetylcholinesterase inhibitor with clear pharmacological activity.
Enhanced Memory Formation
Memory benefits are documented in dementia trials and one adolescent study; healthy adult evidence is thin.
Cognitive Function
Trials in Alzheimer disease show cognitive improvement, but methodological quality is poor and healthy-adult data is minimal.
Neuroprotection
Neuroprotective effects beyond symptomatic cholinergic action are unproven in humans.
Health Concerns Addressed
No linked health concerns yet.
Supporting Research6 studies
Huperzine A for Alzheimer's disease (Cochrane review)
Li J, Wu HM, Zhou RL +2 more
There is currently insufficient evidence of the effects of huperzine A for Alzheimer's disease.
A phase II trial of huperzine A in mild to moderate Alzheimer disease
Rafii MS, Walsh S, Little JT +6 more
The primary outcome, change in ADAS-Cog at week 16, did not differ from placebo.
Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials
Yang G, Wang Y, Tian J +1 more
Huperzine A improved MMSE and activities of daily living scores versus placebo, but all trials had unclear or high risk of bias.
Efficacy and safety of the natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis
Wang BS, Wang H, Wei ZH +3 more
Huperzine A improved MMSE by roughly 2.8 points and ADL scores versus placebo.
Huperzine A in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis
Xing SH, Zhu CX, Zhang R +1 more
Huperzine A significantly improved MMSE and ADL scores in both Alzheimer's disease and vascular dementia.
Huperzine A for mild cognitive impairment: a systematic review of randomised controlled trials
Yue J, Dong BR, Lin X +3 more
No trials of adequate quality were identified for mild cognitive impairment.
Safety Information
Potential Side Effects
Dose-dependent cholinergic effects: nausea, sweating, vivid dreams, insomnia if taken late, muscle twitching or cramps, increased salivation, diarrhoea and bradycardia. These are meaningfully more common than with typical herbal supplements and are the main reason to start low.
Contraindications
Never combine with prescription cholinesterase inhibitors — the effects are additive and potentially dangerous. Avoid with bradycardia, cardiac conduction abnormalities, asthma, COPD, epilepsy and peptic ulcer disease, all of which cholinergic activity can worsen.
Drug Interactions
- Donepezil, rivastigmine and galantamine — additive cholinesterase inhibition, do not combine
- Beta blockers — additive bradycardia
- Anticholinergic drugs — mutually antagonistic
- Succinylcholine and other neuromuscular blockers — prolonged effect; tell your anaesthetist
- Cholinergic drugs including bethanechol — additive effects
Pregnancy & Breastfeeding
Pregnancy: unsafe
Breastfeeding: insufficient_data
Dosage Guidelines
Dosage Used in Studies
50-200 mcg
Best Time to Take
Morning — evening dosing commonly causes vivid dreams and disrupted sleep
Best Form
Isolated or precisely standardised huperzine A, so the microgram dose is unambiguous
Bioavailability
Well absorbed orally. Crosses blood-brain barrier. Potent acetylcholinesterase inhibitor. Long half-life. Start with low dose. Cycle use recommended.
Forms Compared
Huperzine A 1% extract
Isolated huperzine A
Nootropic stacks
Food & Timing
With food to reduce nausea
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.